What is CVS Health PE Ratio (TTM)?
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-09-03), CVS Health's share price is $57.38. CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $5.62. Therefore, CVS Health's PE Ratio (TTM) for today is 10.21.
Good Sign:
CVS Health Corp stock PE Ratio (=10.19) is close to 3-year low of 9.76
The historical rank and industry rank for CVS Health's PE Ratio (TTM) or its related term are showing as below:
CVS' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 9.11 Med: 16.6 Max: 41.87
Current: 10.21
During the past 13 years, the highest PE Ratio (TTM) of CVS Health was 41.87. The lowest was 9.11. And the median was 16.60.
CVS's PE Ratio (TTM) is ranked better than
84.62% of 13 companies
in the Healthcare Plans industry
Industry Median: 19.17 vs CVS: 10.21
CVS Health's Earnings per Share (Diluted) for the threemonths ended in Jun. 2024 was $1.41. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $5.62.
As of today (2024-09-03), CVS Health's share price is $57.38. CVS Health's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was $6.17. Therefore, CVS Health's PE Ratio without NRI for today is 9.31.
During the past 13 years, CVS Health's highest PE Ratio without NRI was 25.50. The lowest was 8.20. And the median was 12.99.
CVS Health's EPS without NRI for the threemonths ended in Jun. 2024 was $1.41. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was $6.17.
During the past 12 months, CVS Health's average EPS without NRI Growth Rate was -17.80% per year.During the past 3 years, the average EPS without NRI Growth Rate was 3.50% per year.During the past 5 years, the average EPS without NRI Growth Rate was 13.80% per year.During the past 10 years, the average EPS without NRI Growth Rate was 6.70% per year.
During the past 13 years, CVS Health's highest 3-Year average EPS without NRI Growth Rate was 35.10% per year. The lowest was -40.50% per year. And the median was 12.90% per year.
CVS Health's EPS (Basic) for the threemonths ended in Jun. 2024 was $1.41. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $5.64.
CVS Health PE Ratio (TTM) Historical Data
The historical data trend for CVS Health's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
CVS Health PE Ratio (TTM) Chart
CVS Health Annual Data | ||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
PE Ratio (TTM) | Get a 7-Day Free Trial | 14.62 | 12.51 | 17.14 | 28.59 | 12.20 |
CVS Health Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
PE Ratio (TTM) | Get a 7-Day Free Trial | 30.19 | 10.53 | 12.20 | 14.02 | 10.51 |
Competitive Comparison of CVS Health's PE Ratio (TTM)
For the Healthcare Plans subindustry, CVS Health's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Health's PE Ratio (TTM) Distribution in the Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, CVS Health's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where CVS Health's PE Ratio (TTM) falls into.
CVS Health PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
CVS Health's PE Ratio (TTM) for today is calculated as
PE Ratio (TTM) | = | Share Price | / | Earnings per Share (Diluted) (TTM) |
= | 57.38 | / | 5.620 | |
= | 10.21 |
CVS Health's Share Price of today is $57.38.
CVS Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.62.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PE Ratio (TTM) | = | Market Cap | / | Net Income |
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
CVS Health(NYSE:CVS) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.
Be Aware
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
CVS Health PE Ratio (TTM) Related Terms
Thank you for viewing the detailed overview of CVS Health's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.
CVS Health Business Description
Industry
GURUFOCUS.COM »STOCK LIST »Healthcare » Healthcare Plans » CVS Health Corp (NYSE:CVS) » Definitions » PE Ratio (TTM)
Comparable Companies
CI HUM CNC ELV MOH OSCR ALHC CLOV NEUE PFHO UNH BSP:ODPV3 SZSE:000503 NSE:MEDIASSIST BJSE:870656 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG MRAI
Traded in Other Exchanges
CVS:Peru CVS:Mexico 1CVS:Italy CVSd:UK 0HRS:UK CVS0:Germany CVS:Germany CVS:Germany CVS:Germany CVS:Chile CVS:Canada CVSH34:Brazil CVS:Austria
Address
One CVS Drive, Woonsocket, RI, USA, 02895
Website
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
Executives
Edward J Ludwig | director | C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417 |
Michael F Mahoney | director | BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234 |
Thomas F. Cowhey | officer: SVP, Interim CFO | 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027 |
J Scott Kirby | director | 233 S. WACKER DRIVE 11TH FL WHQLD, CHICAGO IL 60606 |
Brian A Kane | officer: EVP/President, Aetna | 500 W MAIN STREET, LOUISVILLE KY 40202 |
James David Clark | officer: SVP, Cont & Chief Acct Officer | ONE CVS DRIVE, WOONSOCKET RI 02760 |
Karen S Lynch | officer: EVP & Pres, Aetna Bus Unit | 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156 |
Samrat S. Khichi | officer: EVP, CPO and General Counsel | C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873 |
Thomas M Moriarty | officer: EVP & General Counsel | 100 PARSONS POND DRIVE, FRANKLIN LAKES NJ 07417 |
Jeffrey R. Balser | director | 3657 RICHLAND AVE., NASHVILLE TN 37205 |
Alan Lotvin | officer: EVP, Transformation | 55 NOD ROAD, AVON CT 06001 |
Daniel P Finke | officer: EVP/Pres, Health Care Benefits | ONE CVS DRIVE, WOONSOCKET RI 02895 |
Tilak Mandadi | officer: EVP, Chief Technology Officer | 3600 LAS VEGAS BLVD. SOUTH, LAS VEGAS NV 89109 |
Sreekanth K Chaguturu | officer: EVP and Chief Medical Officer | ONE CVS DRIVE, WOONSOCKET RI 02895 |
Prem S Shah | officer: EVP and Co-President of Retail | ONE CVS DRIVE, WOONSOCKET RI 02895 |
CVS Health Headlines
From GuruFocus
CVS Health to Acquire Signify Health Call Transcript
By GuruFocus Research • 01-22-2024
CVS Health Corp Annual Shareholders Meeting Transcript
By GuruFocus Research • 01-22-2024
Q1 2021 CVS Health Corp Earnings Call Transcript
By GuruFocus Research • 01-22-2024
Q4 2022 CVS Health Corp Earnings Call Transcript
By GuruFocus Research • 01-22-2024
Q2 2023 CVS Health Corp Earnings Call Transcript
By GuruFocus Research • 01-22-2024
Q3 2022 CVS Health Corp Earnings Call Transcript
By GuruFocus Research • 01-22-2024
Q2 2022 CVS Health Corp Earnings Call Transcript
By GuruFocus Research • 01-22-2024
CVS Health Corp at JPMorgan Healthcare Conference Transcript
By GuruFocus Research • 01-22-2024
Q1 2023 CVS Health Corp Earnings Call Transcript
By GuruFocus Research • 01-22-2024
CVS Health Corp at Sanford C Bernstein Strategic Decisions Conference Transcript
By GuruFocus Research • 01-22-2024